おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Osivax
company
About
Osivax is a clinical stage biotechnology company developing a pipeline of vaccines and immunotherapies.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- €15.10M
- Industries
- Biotechnology,Clinical Trials,Health Care
- Founded date
- Jan 1, 2017
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Osivax is a developer of immunotherapy vaccines intended to facilitate the treatment of infectious diseases. The company's vaccines expedite the uptake into dendritic cells and increase the immunogenicity of the natural protein to trigger a more effective immune response, including an unprecedented CD8 T cell activation, enabling medical practitioners to treat patients with cancer as well as influenza, malaria and other infectious diseases effectively.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
€30.10M
Osivax has raised a total of
€30.10M
in funding over 2 rounds. Their latest funding was raised on
Jul 8, 2020 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 8, 2020 | Grant | €15.10M | 1 | — | — | Detail |
| Jul 8, 2020 | Series B | €15M | 1 |
European Innovation Council
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Osivax is funded by 1 investors.
European Innovation Council
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
European Innovation Council
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
